Government
Hundreds of thousands of current, emerging and minority suppliers all in one place
Suppliers
Be found by thousands of government buyers by highlighting keywords, category codes and capabilities
THE JANSSEN PHARMACEUTICAL COMPANIES
PSF Verified1000 U.S. Highway 202, Raritan, NJ 08869, United States
The Janssen Pharmaceutical Companies is a part of Johnson & Johnson. Janssen specifies their major offering areas as: Research & Development, Cardiovascular & Metabolism, Immunology, Neuroscience, Oncology, Infectious Diseases and Vaccines, Pulmonary Hypertension, and Patient Safety Information.
DUNS #:
119237597
CAGE Code:
7QUB7
Type:
Other
Employees:
10,000-50,000
Annual Revenue:
$500M-$1B
Year Founded:
2001
Country of Origin:
United States
Sectors Served:
US Federal
Company Security Level:
Unknown
Credit Card Usage:
No
Specialties and Expertise:
Neuroscience, Infectious Diseases and Vaccines, Metabolism, R&D Retinal Disease, Pulmonary Hypertension, Cardiovascular, Molecule Therapies, Novel Therapeutic, HIV Therapy, Viral Respiratory Diseas...Contact/Location Info5
Government POC
Government POC
Mailing
Size and minority status
Size
Other than small business
Ownership
African American
Alaska Native
Asian-Indian
Asian-Pacific
Hispanic
Minority-Unspecified
Native American
Native Hawaiian
Tribal
Unspecified
Veteran
Woman
Government Set-Aside Programs
AbilityOne
HUBZone
SBA 8(a)
SDVOSB
Small Disadvantaged Business (SDB)
Woman Owned Small Business (WOSB)
Commodity Codes4
PRODUCTS AND SERVICES4
Cardiovascular & Metabolism (CVM)
Janssen provides therapies to prevent and treat cardiovascular, metabolic and retinal diseases.
Infectious Diseases & Vaccines
1 past experience
Janssen has developed novel therapeutics and vaccines to treat and cure infectious diseases such as Viral Hepatitis, Human Immunodeficiency Virus (HIV), Respiratory Syncytial Virus (RSV), Polio, and Ebola.
Immunology
Janssen provides anti-tumor necrosis factor-alpha (TMF) therapy for the treatment of gastroenterology, rheumatology, and dermatology.
AdVac Technology
AdVac adenovirus vector technology is to develop recombinant vaccines against life-threatening infectious diseases.
Past experience1
other
Development of Vaccines to Protect Against ...
Janssen and the Biomedical Advanced Research and Development Authority (BARDA), a component of ASPR, will share research and develop...
Known Locations Served2
My Notes
